{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:42Z","timestamp":1760060022625,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation (NRF)","award":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"],"award-info":[{"award-number":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"]}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"],"award-info":[{"award-number":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT","doi-asserted-by":"publisher","award":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"],"award-info":[{"award-number":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"],"award-info":[{"award-number":["2021R1I1A1A01044500","2021R1C1C1003735","21153MFDS601"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Cancer patients are particularly susceptible to infections caused by multidrug-resistant Gram-negative bacteria (MDR GNB) due to chemotherapy- or radiation therapy-induced immunosuppression. Colistin is often prescribed as a last-resort agent for MDR GNB infection, but its clinical benefit in oncology patients remains unclear. This study aims to evaluate the mortality risk associated with colistin versus non-colistin regimens in cancer patient with MDR GNB infections, stratified by resistance profiles, infection sites, and concomitant medication use. Materials and Methods: A retrospective cohort study was conducted in adult cancer patients with MDR GNB infections that are resistant to at least three antibiotic classes and identified from at least two anatomical sites at a tertiary care hospital in Korea. Propensity score-matched in a 1:3 ratio either to the colistin group or non-colistin group and multivariate Cox hazard regression analyses were used to evaluate mortality in cancer patients with MDR GNB infections, primarily Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Results: A total of 85 patients (29 patients in the colistin and 56 patients in the non-colistin group) were included in the analysis. Overall, colistin use did not show a statistically significant mortality benefit compared to non-colistin regimens (hazard ratio (HR) 0.93, 95% CI 0.47\u20131.87). However, the subgroup analysis revealed that colistin had a potential association with significantly lower mortality in pneumonia patients with aminoglycoside-resistant infections (HR 0.04, 95% CI 0.002\u20130.69). Concomitant use of antipsychotics and benzodiazepines in selected resistance profiles also correlated with improved outcomes. In contrast, a potential association was found between concomitant macrolide use and increased mortality in patients with fluoroquinolone- or penicillin-resistant profiles. Conclusions: Colistin may offer survival benefits in selected high-risk cancer patients with MDR GNB pneumonia. Treatment outcomes are influenced by resistance profiles, infection sites, and concomitant medications, indicating the significant importance of individualized antimicrobial therapy and antimicrobial stewardship in oncology patients.<\/jats:p>","DOI":"10.3390\/medicina61081361","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:57:24Z","timestamp":1753689444000},"page":"1361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mortality Risk of Colistin vs. Non-Colistin Use in Cancer Patients with Multidrug-Resistant Gram-Negative Bacterial Infections: Stratified by Resistance Profile and Concomitant Medications"],"prefix":"10.3390","volume":"61","author":[{"given":"Soo Hyeon","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea"},{"name":"Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul 02447, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwon","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, School of Medicine, Ajou University, Suwon 16499, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ajou University Hospital, Suwon 16499, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-4374","authenticated-orcid":false,"given":"Yeo Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea"},{"name":"Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul 02447, Republic of Korea"},{"name":"Department of Pharmacy, College of Pharmacy and Institute of Integrated Pharmaceutical Sciences, Kyung Hee University, Seoul 02447, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2388-1122","authenticated-orcid":false,"given":"Sooyoung","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea"},{"name":"Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon 16499, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(24)02081-6","article-title":"Multidrug-resistant Gram-negative bacterial infections","volume":"405","author":"Macesic","year":"2025","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S2666-5247(22)00355-X","article-title":"Antimicrobial resistance in patients with COVID-19: A systematic review and meta-analysis","volume":"4","author":"Langford","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jiph.2024.03.021","article-title":"Clinical outcomes of colistin methanesulfonate sodium in correlation with pharmacokinetic parameters in critically ill patients with multi-drug resistant bacteria-mediated infection: A systematic review and meta-analysis","volume":"17","author":"Son","year":"2024","journal-title":"J. Infect. Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mo, S.H., Lee, S.H., Choi, C.-Y., Sunwoo, Y., Shin, S., and Choi, Y.J. (2025). A Comprehensive 10-Year nationwide pharmacovigilance surveillance on antibacterial agents in Korea: Data mining for signal detection of trends and seriousness of adverse events. Microorganisms, 13.","DOI":"10.3390\/microorganisms13010136"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sousa, S.A., Feliciano, J.R., Pita, T., Soeiro, C.F., Mendes, B.L., Alves, L.G., and Leit\u00e3o, J.H. (2021). Bacterial nosocomial infections: Multidrug resistance as a trigger for the development of novel antimicrobials. Antibiotics, 10.","DOI":"10.3390\/antibiotics10080942"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhin.2020.09.006","article-title":"Acquisition of MDR-GNB in hospital settings: A systematic review and meta-analysis focusing on ESBL-E","volume":"106","author":"Vink","year":"2020","journal-title":"J. Hosp. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","article-title":"Infections in cancer patients with solid tumors: A Review","volume":"6","author":"Rolston","year":"2017","journal-title":"Infect. Dis. Ther."},{"key":"ref_8","first-page":"383","article-title":"Use of broad-spectrum antibiotics in adult cancer patients presenting to emergency department with non-neutropenic fever and\/or suspected infection","volume":"33","author":"Li","year":"2025","journal-title":"Support Care Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/iju5.12783","article-title":"Severe neutropenia caused by palliative radiation therapy in a case of metastatic hormone-sensitive prostate cancer","volume":"7","author":"Maesaka","year":"2024","journal-title":"IJU Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Park, K.-H., Jung, Y.J., Lee, H.J., Kim, H.J., Maeng, C.H., Baek, S.K., Han, J.J., Jeon, W., Kim, D.Y., and Lee, Y.-M. (2024). Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-66524-w"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bassetti, M., Peghin, M., Vena, A., and Giacobbe, D.R. (2019). Treatment of infections due to MDR gram-negative bacteria. Front. Med., 6.","DOI":"10.3389\/fmed.2019.00074"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eAO6704","DOI":"10.31744\/einstein_journal\/2022AO6704","article-title":"Factors associated with multidrug-resistant bacteria in healthcare-associated infections: A pediatric intensive care unit case-control study","volume":"20","author":"Silva","year":"2022","journal-title":"Einstein"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/mdr.1998.4.339","article-title":"Impact of antibiotic resistance on chemotherapy for pneumococcal infections","volume":"4","author":"Pallares","year":"1998","journal-title":"Microb. Drug Resis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ygyno.2020.09.010","article-title":"Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer","volume":"159","author":"Chambers","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jointm.2023.12.007","article-title":"Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review","volume":"4","author":"Roger","year":"2024","journal-title":"J. Intensive Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mourad, D.F., Radwan, S., Hamdy, R., Elkhashab, D.M., Kamel, M.M., Abdel-Moneim, A.S., and Kadry, D.Y. (2024). Identification of lower respiratory tract pathogens in cancer patients: Insights into fatal outcomes. Microorganisms, 12.","DOI":"10.3390\/microorganisms12081686"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1128\/AAC.01015-06","article-title":"Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients","volume":"51","author":"Jiang","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.1007\/s13369-024-08830-z","article-title":"Effectiveness and safety of colistimethate sodium used in the treatment of neutropenic blood cancer patients infected with multidrug-resistant Pseudomonas aeruginosa","volume":"49","author":"Salman","year":"2024","journal-title":"Arab. J. Sci. Eng."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jo, H.G., Jeong, K., Ryu, J.Y., Park, S., Choi, Y.S., Kwack, W.G., Choi, Y.J., and Chung, E.K. (2021). Fatal events associated with adverse drug reactions in the Korean national pharmacovigilance database. J. Pers. Med., 12.","DOI":"10.3390\/jpm12010005"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acs.accounts.1c00020","article-title":"Discovery of macrolide antibiotics effective against multi-drug resistant gram-negative pathogens","volume":"54","author":"Myers","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1093\/infdis\/jiae639","article-title":"Addition of macrolide antibiotics for hospital treatment of community-acquired pneumonia","volume":"231","author":"Wei","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101214","DOI":"10.1016\/j.lanepe.2025.101214","article-title":"2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies","volume":"51","author":"Sandherr","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Morita, Y., Tomida, J., and Kawamura, Y. (2014). Responses of Pseudomonas aeruginosa to antimicrobials. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00422"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jgar.2024.07.016","article-title":"Understanding the evolution of macrolides resistance: A mini review","volume":"38","author":"Shahrulzamri","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jpsychires.2025.05.046","article-title":"Systematic examination of off-target effects of antipsychotic medications associated with microbiome disruption and heightened bacterial infection risks","volume":"189","author":"McDonagh","year":"2025","journal-title":"J. Psychiatr. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2215-0366(24)00223-2","article-title":"Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: A Danish nationwide registry study","volume":"11","author":"Nersesjan","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1111\/bcp.14321","article-title":"Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study","volume":"86","author":"Wang","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2209736","DOI":"10.1080\/07853890.2023.2209736","article-title":"Association between anticholinergic medication uses and the risk of pneumonia in elderly adults: A meta-analysis and systematic review","volume":"55","author":"Wu","year":"2023","journal-title":"Ann. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s41999-023-00837-3","article-title":"Therapeutic dilemma\u2019s: Antipsychotics use for neuropsychiatric symptoms of dementia, delirium and insomnia and risk of falling in older adults, a clinical review","volume":"14","author":"Tiihonen","year":"2023","journal-title":"Eur. Geriatr. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102507","DOI":"10.1016\/j.eclinm.2024.102507","article-title":"Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: An international scoping review","volume":"70","author":"Brandt","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40263-024-01108-w","article-title":"Incident benzodiazepine and Z-drug use and subsequent risk of serious infections","volume":"38","author":"Wang","year":"2024","journal-title":"CNS Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Park, H.Y., Kwon, J., An, S.K., and Park, E.-C. (2022). A nationwide cohort study of the association of benzodiazepines with SARS-CoV-2 infection and clinical outcomes. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-20335-z"},{"key":"ref_36","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-23-0547","article-title":"Lorazepam stimulates IL6 production and is associated with poor survival outcomes in pancreatic cancer","volume":"29","author":"Cornwell","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13054-024-05073-0","article-title":"Septic shock in immunocompromised cancer patient: A narrative review","volume":"28","author":"Nates","year":"2024","journal-title":"Crit. Care"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:05Z","timestamp":1760033825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081361"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081361","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}